Esben N. Flindt

670 citations
8 papers · 429 indexed · h-index 8
Topics
Peroxisome Proliferator-Activated Receptors (7 papers)Cancer, Lipids, and Metabolism (2 papers)Adipose Tissue and Metabolism (2 papers)
Partner nations
DenmarkNorwayFrance

In The Last Decade

Esben N. Flindt

8 papers receiving 421 citations

Peers

Esben N. Flindt
Comparison fields: 5 of 69
  • Molecular Biology 326
  • Physiology 127
  • Cancer Research 86
  • Immunology 59
  • Biochemistry 52
Replace Roxane Mansouri with:
Roxane Mansouri France
M E Wernette-Hammond United States
M E Pape United States
Chen S. Suen United States
Barbara J. Palazuk United States
Valentina Fabbroni Italy
Jessica Roos Germany
Yuko Yamakawa Japan
Kyeojin Kim South Korea
Marija Rakonjac Sweden
Esben N. Flindt relative to Roxane Mansouri France Roxane Mansouri's profile →
Citations per field
00.5×2.6×
Roxane Mansouri · 1×
Citations per year

Countries citing papers authored by Esben N. Flindt

Since Specialization
Citations

This map shows the geographic impact of Esben N. Flindt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Esben N. Flindt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Esben N. Flindt more than expected).

Fields of papers citing papers by Esben N. Flindt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Esben N. Flindt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Esben N. Flindt. The network helps show where Esben N. Flindt may publish in the future.

Co-authorship network of co-authors of Esben N. Flindt

This figure shows the co-authorship network connecting the top 25 collaborators of Esben N. Flindt. A scholar is included among the top collaborators of Esben N. Flindt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Esben N. Flindt. Esben N. Flindt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
#WorkIndexed citations
1 28
2 54
3 24
4 53
5 48
6 58
7 149
8 15

About Esben N. Flindt

Esben N. Flindt is a scholar working on Cancer Research, Molecular Biology and Physiology, having authored 8 papers that have together received 429 indexed citations. Recurring topics across this work include Peroxisome Proliferator-Activated Receptors (7 papers), Cancer, Lipids, and Metabolism (2 papers) and Adipose Tissue and Metabolism (2 papers). The work is most often cited by research in Biochemistry (52 citations), Cancer Research (86 citations) and Physiology (127 citations). Esben N. Flindt has collaborated with scholars based in Denmark, Norway and France. Frequent co-authors include Karsten Kristiansen, Rasmus K. Petersen, Thomas Rasmussen, Hongbin Zhang, Jacob B. Hansen, Rolf K. Berge, Kjetil Berge, Karl Johan Tronstad, Lise Madsen and Knud Kragballe. Their work appears in journals such as Journal of Biological Chemistry, Journal of Medicinal Chemistry and Journal of Lipid Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026